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Abstract
Researchers designing clinical trials often specify usual care received by participants as the control 
condition expecting that all participants receive usual care regardless of group assignment. The 
assumption is that the groups in the study are affected similarly. We describe the assessment of 
usual care within the 16 studies in MACH 14, a multi-site collaboration on adherence to 
antiretroviral therapy. Only five of the studies in MACH 14 assessed usual care. Assessment 
protocols varied as did the timing and frequency of assessments. All usual care assessments 
addressed patient education focused on HIV, HIV medications, and medication adherence. Our 
findings support earlier work that calls for systematic assessments of usual care within the study 
design, inclusion of descriptions of usual care in reports of the study, and the influence of usual 
care on the experimental condition in clinical trials.
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Investigators conducting clinical trials often specify that the usual health care provided to 
patients who participate in those trials is the control condition. A basic assumption 
underlying these trials is that all participants in the study, regardless of their study group 
assignment. continue to receive the usual care provided within the clinical setting. 
Differences detected in the outcomes at the end of the study are expected to be due to the 
experimental condition used in the study since that is what is different between the two or 
more groups (Hulley, Cummings, Browner, Grady, & Newman, 2007). However, during the 
study, when there is new evidence, there is the distinct possibility that health care providers 
may modify usual care. Thus, the assessment and influence of usual care become important 
considerations when examining the outcomes of a study.
Assessing Usual Care
Modifications in treatment guidelines in the clinical management of patients with HIV/AIDS 
have advanced because of drug discoveries and the emergence of new evidence regarding 
their effectiveness and impact on a patient's clinical outcomes (Panel on Antiretroviral 
Guidelines for Adults and Adolescents, 2013). Such changes in the delivery of usual care 
have the potential to affect the hypothesized outcomes in an ongoing study when the 
changes are introduced. All patients who participate in the study receive what is deemed to 
be usual care. However, these participants may not all receive the same usual care 
depending on the rate of adoption of the revisions to treatment guidelines at the study site, 
the level of adherence to the guidelines by the health care providers, and when the 
participants were recruited into the study. Clearly, usual care is a dynamic condition in 
which health care providers alter their management of patients based on the latest evidence.
Wagner and Kanouse (2003) in their seminal discussion offered three reasons to assess usual 
care when conducting clinical trials designed to examine the effect of an intervention on 
adherence to antiretroviral therapy (ART) prescribed for HIV infected patients. First, 
describing usual care, as well as the intervention is necessary for another practice setting to 
determine whether the tested intervention has the potential to be adopted and effective 
within a different setting. This is particularly important given the current focus on 
translating research into practice (Glasziou et al., 2010). Additionally, in a multi-site study 
differences in usual care may provide the explanation for the site differences that occurred in 
regard to the outcomes. However, this explanation can only be offered when usual care is 
consistently monitored at each of the participating sites. Lastly, health care providers who 
are also the researchers may begin to change the management of patients in their practice 
and knowingly or unknowingly provide different care to the participants in the usual care 
arm. Although, Wagner and Kanouse (2003) focused their comments on ART adherence 
research, they did not limit the monitoring of usual care to only those trials; they emphasized 
the need to assess usual care in other studies that include a behavioral intervention.
In 2009, de Bruin, Viechtbauer, Hospers, Schaalma, and Kok called for investigators to 
report usual care to improve the accuracy of the assessment of change that occurred as a 
result of a behavioral intervention being tested within a clinical trial. Williams (2010) 
supported this position stating that the components and processes occurring during usual 
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care are important to the overall conduct of the clinical trial. When usual care is based on the 
latest evidence, it may include components that are also within the behavioral intervention 
that is being tested in the trial such as health teaching to promote better medication 
management (de Bruin et al., 2010). The meta-analysis conducted by de Bruin and 
colleagues (2010) showed that the intervention arm performed better when there was a lower 
level of usual care provided. As the level of usual care increased and included more of the 
components in the intervention, there was less effect demonstrated by the intervention being 
tested (de Bruin et al., 2010; Williams, 2010).
Yet, investigators do not typically describe the usual care condition within the methods 
section of a published paper raising questions regarding what is actually included in usual 
care, whether usual care was monitored for any changes in delivery during the study, and 
how changes in usual care may have affected the hypothesized outcomes (de Bruin et al., 
2009). Without this information the internal validity of the study is threatened (Polit & 
Beck, 2012). Descriptions of usual care are even more problematic when a study uses 
multiple sites because of possible variation in usual care across clinics and differences in 
practices based on geographic location (Freedland, Mohr, Davidson, & Schwartz, 2011). 
Also, whether individuals within a site or sites are randomized within a study needs to be 
considered.
Despite the need for and value of assessing usual care, only a few methods for monitoring 
the control condition in a study have been described (Carroll, 1997; Garland, Hurlburt, 
Brookman-Frazee, Taylor, & Accurso, 2010). The use of a Theory Coding Scheme designed 
to capture the components of the theory that are present in the interventions that are 
delivered in an RCT could be extended to the systematic assessment of usual care (Michie, 
Prestwich, & de Bruin, 2010). Similarly, the importance of assessing adherence to treatment 
guidelines cannot be overlooked. Another possible usual care assessment, the Session 
Report Form developed for a larger clinical trial, has been suggested by Kelley, Vides de 
Andrade, Sheffer, and Bickman (2010). The form is completed by health care providers at 
the end of a usual care session designed for youth being seen for mental health conditions to 
inform the content addressed and the context in which usual care occurred. Possibly patients 
could be informants about usual care; however, they may be unable to differentiate the usual 
care provided to all patients in the clinic setting from the individualized care that they are 
receiving.
Purpose
Although systematic assessment of usual care has clear advantages in clinical trials with a 
behavioral intervention, usual care does not necessarily lend itself to rigorous, reliable, or 
feasible assessment. To our knowledge no standard form for assessing usual care is 
described in published studies. Additionally, there are few reports available to inform how 
best to monitor usual care. This paper describes the assessment of usual care within the 16 
studies of the MACH 14 (Multi-site Adherence Collaboration in HIV among 14 institutions) 
collaborative group (Liu et al., 2013) and offers insight into current research practice using 
those studies as examples when conducting and reporting results from clinical trials.
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Data for this descriptive study examining the practice of assessing usual care were provided 
by the sample of principal investigators within the MACH 14 collaboration and were 
collected after the studies had ended. MACH 14 includes 16 NIH-funded studies conducted 
at 14 different sites in various regions of the United States from 1997 to 2009. Each study 
focused on medication adherence in patients with HIV/AIDS in which the outcome of 
adherence in both the usual care/control and intervention arms was assessed using electronic 
event monitors (Liu et al., 2013). All studies in MACH 14 received approval from their 
respective organization's institutional review board.
Sample
Twelve of the 16 studies (75%) in MACH 14 were intervention studies Liu et al., 2013). The 
length of the interventions within these studies varied from 5 to 23 weeks. The experimental 
condition focused on improving medication adherence and directly or indirectly targeted the 
participant's behavior. The interventions included one or more of the following components: 
directly observed therapy, problem solving, counseling, feedback to the participant, peer 
counseling, and feedback to the physician. Theories and models supporting the interventions 
incorporated social cognitive theory, contingency management, self-regulation, and 
motivational interviewing.
Data Collection
MACH 14 investigators initially provided a brief written summary of their intervention and 
usual care/control study groups. Because these descriptions were rather general, we sought 
more specific information regarding the assessment of usual care in the 16 studies. We 
developed a questionnaire for the MACH 14 researchers to complete. If the researchers 
answered “yes” that they monitored usual care, we asked them to describe how usual care 
was assessed, when usual care was assessed, the frequency of the assessments, who 
provided the assessment data, how the data were obtained, and the specific clinical practices 
within usual care that were assessed. We also invited investigators to provide any additional 
comments relevant to the assessment of usual care in their particular clinical settings.
Data Analysis
We reviewed each of the general descriptions of usual care provided by the MACH 14 
researchers to get a sense of their use of the term “usual care”. We summarized the data 
from the questionnaires using descriptive statistics, for example, frequencies and percents.
Results
The initial written descriptions showed that two-thirds (n=10) of the investigators identified 
usual care as the “procedures provided to all patients”. However, when referring to the 
control condition in their clinical trials, the researchers used diverse terms such as usual 
care, standard clinic care, standard patient education, or comparison condition. While there 
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was agreement regarding the definition of usual care, there was variability in how the 
control condition was defined. Usual care was one example of the control condition.
Our findings showed that only one-third of the studies in Mach 14 (n=5) assessed usual care. 
Responses to how usual care was assessed demonstrated that investigators in four of the 
studies developed a study-specific form for assessing usual care. However, in the fifth study, 
the researchers who were also the health care providers in that setting, stated that they were 
familiar with the usual care practices and therefore did not conduct regular assessments of 
usual care.
The frequency of the assessments of usual care varied. Four studies assessed usual care at 
both the beginning and at the end of the study. Two of those four studies also monitored 
usual care at 3 or 6 month intervals throughout the study. One study assessed usual care only 
at the beginning; this study was the one where the health care porviders were also the 
researchers. The investigators collected usual care data by telephone, face to face, 
electronically, or mail. Most informants providing usual care assessment data were direct 
care providers within the practice site. For the longitudinal studies that collected usual care 
data more often, different personnel within the setting provided the information. Thus, there 
was not continuity across informants.
The clinical practices within usual care that were assessed included HIV medical care 
(referrals, laboratory monitoring, and physical examinations) and patient education related 
to HIV infection, HIV medications, and medication adherence. Another practice in the 
setting that was assessed was a patient's level of medication adherence when that individual 
was seen for their clinic appointment.
Discussion
Recognizing the importance of the role of usual care in clinical trials, we set out to describe 
the manner in which usual care was assessed within the 16 studies included in the MACH 14 
collaboration as a means of showing the current research practice when conducting clinical 
trials. The MACH14 sample included both intervention and non-intervention studies from 
across the United States; these studies spanned nearly 15 years (Liu et al., 2013). During that 
time there were new drug discoveries that changed antiretroviral treatment guidelines 
potentially altering the usual care provided to patients with HIV participating in these 
longitudinal studies (Panel on Antiretroviral Guidelines for Adults and Adolescents, 2013).
The findings available in this report demonstrate that there was limited systematic 
monitoring of usual care in the trials included in MACH 14. MACH 14 was a convenience 
sample of studies that assessed adherence to antiretroviral therapy using electronic event 
monitors, as well as other bio-behavioral measures. The assessment of usual care was not a 
criterion for a study's inclusion in MACH 14. The five studies monitoring usual care were 
all intervention trials and each had assessments at the beginning of those studies; most 
assessed usual care at the end of the study. Only a few studies assessed usual care at 
intervals throughout the course of the study. Researchers in MACH 14 conducting non-
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intervention studies did not monitor usual care. However, the significance of usual care in 
observational studies is no less important.
No consistent form for assessing usual care was used across the studies; each study 
developed its own form. Only particular aspects of usual care within a practice setting may 
have been included on the assessment form thus limiting the amount of information that was 
obtained and that could be used to determine the role of usual care on the study outcomes. 
While these studies attempted to capture any changes in usual care, having more objective 
measures is preferred and makes tracking changes over time more precise.
Who provided the information about usual care may have affected the information that was 
collected and made it challenging for the researcher to obtain objective and nonbiased data 
about current clinic practices. There may have been a “Hawthorne effect” or a social 
desirability effect when reporting data on usual care practices.
Because participants in some of the studies within MACH 14 were enrolled for 12 months or 
longer and the interventions lasted between 5-23 weeks, there was the distinct possibility 
that the usual care provided to participants may have differed by the time all participants 
were enrolled into and completed a particular study. When usual care is monitored only at 
the start of the study, it is not possible to know if any changes occurred in patient care 
practices over the length of the investigation or whether the usual care began to include 
aspects of the experimental condition. If participants are recruited from the community, as 
well as clinics, it is not possible to gather data on usual care from all the practices where 
participants received their care. Thus, the usual care received by participants recruited from 
the community is unknown.
Our limited findings show that usual care assessments occurred intermittently, even those 
that occurred at multiple time points within a study. With intermittent monitoring 
assessments may not be done at the time an evidenced-based practice change was 
introduced. Additionally, summarizing the common elements within usual care when there 
are multiple health care providers in the practice setting is difficult as all providers may not 
manage their patients in the same way. The variability of the available services and what 
individual patients are offered and receive is difficult to capture within a standardized usual 
care assessment form.
This brief report demonstrates the limited assessment of usual care within both clinical trials 
and observational studies in MACH 14 supporting findings from earlier meta-analyses, as 
well as commentaries calling for the need to assess usual care. How the assessment data was 
used in the analyses within these studies is unknown. Assessing usual care is important to 
understand the potential impact of changes in clinical practice during the length of a study. 
A description of the usual care provided to study participants needs to be included when 
reporting the study findings. Without a clear depiction of usual care, it becomes difficult to 
make comparisons across studies and conduct systematic reviews or meta-analyses (de 
Bruin et al., 2009).
This report suggests that there is a need to develop a protocol within the study to 
systematically assess usual care throughout the study. Regardless of the research design a 
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process similar to that for monitoring intervention fidelity should be considered 
(Wickersham et al., 2011; Glasziou et al., 2010). Monitoring usual care throughout a study 
and incorporating those data into the analysis will assist researchers to include the influence 
of usual care on the outcomes of the study and offer changes in usual care as a potential 
explanation for the findings in the study. Refer to Table 1 for the categories of assessment 
and recommendations for monitoring usual care.
Acknowledgements
This research was supported by the multi-site adherence collaboration in HIV (MACH14) grant R01MH078773 
from the National Institute of Mental Health (NIMH), Office on AIDS. The original grants of individual 
participating studies are: R01DA11869, MH54907, 2R01NR04749, R01NR04749, MH68197, R01 DA13826, 
K23MH01862, MH01584, R01 AI41413, R01 MH61173, NIH/ NIAID AI38858, AI069419, K02 DA017277, 
R01DA15215, NIMH P01 MH49548, MH58986, RO1MH61695, CC99-SD003, CC02-SD-003 and 
R01DA015679. We would like to thank all the patients who participated in each of the individual studies. The 
content of the paper is solely the responsibility of the authors and does not necessarily represent the official views 
of the National Institutes of Health.
References
Carroll KM. Manual-guided psychosocial treatment: A new virtualrequirement for 
pharmacotherapytrails? Archives of General Psychiatry. 1997; 54:923–928. doi:10.1001/archpsyc.
1997.01830220041007. [PubMed: 9337772] 
de Bruin M, Viechtbauer W, Hospers HH, Schaalma HP, Kok G. Standard care quality determines 
treatment outcomes in control groups of HAART-adherence intervention studies: Implications for 
the interpretation and comparison of intervention effects. Health Psychology. 2009; 28:668–674. 
doi:10.1037/a0015989. [PubMed: 19916634] 
de Bruin M, Viechtbauer W, Schaalma HP, Kok G, Abraham C, Hospers HJ. Standard care impact on 
effects of highly active antiretroviral therapy adherence interventions: A meta-analysis of 
randomized controlled trials. Archives of Internal Medicine. 2010; 170:240–250. doi:10.1001/
archinternmed.2009.536. [PubMed: 20142568] 
Freedland KE, Mohr DC, Davidson KW, Schwartz JE. Usual and unusual care: Existing practice 
control groups in randomized controlled trials of behavioral interventions. Psychosomatic Medicine. 
2011; 73:323–335. doi: 10.1097/PSY.0b013e318218e1fb. [PubMed: 21536837] 
Garland AF, Hurlburt MS, Brookman-Frazee L, Taylor RM, Accurso EC. Methodological challenges 
of characterizing usual care psychotherapeutic practice. Administration and Policy in Mental Health 
and Mental Health Services Research. 2010; 37:208–220. doi 10.1007/s10488-009-0237-8. 
[PubMed: 19757021] 
Glasziou P, Chalmers I, Altman DG, Bastian H, Boutron I, Brice A, Williams JW. Taking healthcare 
interventions from trial to practice. British Medical Journal. 2010; 341:c3582. doi:10.1136/
bmjc3852. [PubMed: 20610503] 
Hulley, SB.; Cummings, SR.; Browner, WS.; Grady, DG.; Newman, TB. Designing clinical research. 
3rd ed.. Lippincott Williams & Wilkins; Philadelphia, PA: 2007. 
Kelley SD, Vides de Andrade AR, Sheffer E, Bickman L. Exploring the black box: Measuring youth 
treatment process and progress in usual care. Administration and Policy in Mental Health and 
Mental Health Services Research. 2010; 37:287–300. doi: 10.1007/s10488-010-0298-8. [PubMed: 
20238155] 
Liu H, Wilson IB, Goggin K, Reynolds N, Simoni JM, Golin CE, Bangsberg DR. MACH 14: A multi-
site collaboration on ART adherence among 14 institutions. AIDS and Behavior. 2013; 17:127–141. 
doi: 10.1007/s10461-012-0272- 4. [PubMed: 22864921] 
Michie S, Prestwich A, de Bruin M. Importance of the nature of comparison conditions for testing 
theory-based interventions: Reply. Health Psychology. 2010; 29:468–470. doi: 10.1037/a0020844. 
Erlen et al. Page 7













Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral 
agents in HIV-1-infected adults and adolescents. 2013. Retrieved from http://aidsinfo.nih.gov/
contentfiles/lvguidelines/AdultandAdolescentGL.pdf
Polit, DF.; Beck, CT. Nursing research: Generating and assessing evidence for nursing practice. 9th 
ed.. Wolters Kluwer Health; Philadelphia, PA: 2012. 
Wagner GJ, Kanouse DE. Assessing usual care in clinical trials of adherence interventions for highly 
active antiretroviral therapy. Journal of Acquired Immune Deficiency Syndromes. 2003; 33:276–
280. [PubMed: 12794566] 
Wickersham K, Colbert A, Caruthers D, Tamres L, Martino A, Erlen JA. Assessing fidelity to an 
intervention in a randomized controlled trial to improve medication adherence. Nursing Research. 
2011; 60:264–269. doi:10.1097/NNR.0b013e318221b6e6. [PubMed: 21677597] 
Williams DM. Importance of the nature of comparison conditions for testing theory-based 
interventions: Comment on Michie and Prestwich. Health Psychology. 2010; 29:467. doi: 10.1037/
a0019597. [PubMed: 20836599] 
Erlen et al. Page 8

























Erlen et al. Page 9
Table 1
Recommendations for Assessing Usual Care in Clinical Trials
Focal area Recommendations
Study specific instrument Develop a study specific form or modify a form so that it is specific to the study a priori
Consider developing a more detailed form rather than one that has broad categories in order to collect relevant 
information
Include space for dates for any changes in clinic practices; provide space for identifying the changes
Include space for frequencies of ongoing events such as labs and follow-up appointments
Content Include questions related to:
    Clinic visits including initial vs. follow-up, laboratory tests, physical examinations
    Usual frequency of clinic visits
    Referral services such as psychiatric -mental health or social service
    Special programs that are offered such as peer support groups
    Educational services such as review of medications, medication management/adherence, nutrition
    Programmatic and/or clinic changes including the nature of the change and date when the change occurred
    Other regular occurrences within the clinical management of patients
Study data collector Identify usual care data collection as a specific position responsibility for a member of the research staff
Ensure that staff member has a clinical background
Prepare a study specific protocol for collecting usual care data
Provide training regarding the protocol for collecting usual care information
Conduct periodic quality assessments of usual care data collection
Conduct ant retraining of study staff, as necessary
Clinic Informant Identify one consistent person from the healthcare agency/clinic who is knowledgeable about the clinic's practices
Provide training for the designated informant in order to ensure accurate and complete data collection
Timing Collect data at the beginning, end, and at intervals during the study
Track the date for each usual care data collection
Arrange a convenient date and time with the clinic informant for collecting usual care data
Mechanism Collect data using an on-site face to face interview (preferred approach at least for the initial data collection)
Use telephone interview or electronic/mail data collection if unable to use on-site approach
Enter data into a database as soon after the data collection as possible
Contact the clinic informant to obtain any missing data or to clarify any of the information
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